Dynamic Function of DPMS Is Essential for Angiogenesis and Cancer Progression

Area of Science:

• Biochemistry and Molecular Biology
• Enzymology
• Glycobiology

Background:

• Dolichol phosphate mannose synthase (DPMS) is a GT2 enzyme involved in protein glycosylation.
• DPMS plays a role in N-glycan biosynthesis, GPI anchor synthesis, and protein mannosylation.
• DPMS activity is linked to cellular proliferation, angiogenesis, and breast tumor progression.

Purpose of the Study:

• To investigate the role of DPMS in breast tumor progression and its potential as a therapeutic target.
• To explore the effects of inhibiting DPMS activity on cancer cell proliferation and related pathways.

Main Methods:

• Analysis of DPMS sequence motifs and transmembrane domains.
• Investigation of DPMS regulation by protein phosphorylation and cAMP signaling.
• Study of DPMS interaction with N-acetylglucosaminyl 1-phosphate transferase (GPT) and tunicamycin inhibition.
• Evaluation of nano-formulated tunicamycin's effects on cell cycle progression and DPMS expression.

Main Results:

• DPMS overexpression enhances N-glycosylation, cellular proliferation, and angiogenesis in endothelial cells.
• Inhibition of GPT by tunicamycin downregulates DPMS activity, impairing N-glycan expression and inhibiting tumor cell proliferation.
• Nano-formulated tunicamycin is more potent in inhibiting cell cycle progression and downregulating DPMS expression without inducing apoptosis.

Conclusions:

• DPMS is a critical enzyme in cancer development, influencing proliferation and angiogenesis.
• Targeting DPMS offers a potential strategy for developing novel glycotherapy for breast tumors.
• DPMS represents a promising novel target for therapeutic intervention in clinical oncology.